Advertisement

Topics

Ra Pharmaceuticals Receives Orphan Drug Designation from the U.S. ...

03:06 EDT 31 Jul 2017 | BioMedReports - Blog
Investors:
Ra Pharmaceuticals, Inc.
Jennifer Robinson, 617-674-9873
jrobinson@rapharma.com
or
Media:
Argot Partners
Eliza Schleifstein, 917-763-8106
eliza@argotpartners.com

Read more...

Original Article: Ra Pharmaceuticals Receives Orphan Drug Designation from the U.S. ...

NEXT ARTICLE

More From BioPortfolio on "Ra Pharmaceuticals Receives Orphan Drug Designation from the U.S. ..."

Quick Search
Advertisement